Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.056 | 0.7 |